Erasca, Inc. (NASDAQ:ERAS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lin Wei Other companies: TCGX Acquisition Corp. (Director · Since at least Aug 4, 2026); Revolution Medicines, Inc. (Chief Medical Officer · Since at least Mar 21, 2024); 2Seventy Bio Inc (Director · Mar 7, 2023 – May 13, 2025 · Past) | Chief Medical Officer · Jul 15, 2021 – Feb 1, 2023 · Past |
| James Bristol Other companies: Ernexa Therapeutics Inc. (Chairman · Since at least Oct 30, 2023); Deciphera Pharmaceuticals LLC (Director · Jun 11, 2024 – Jun 11, 2024 · Past) | Director · Since at least Jan 1, 2024 |
| Jean Liu Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Seagen Inc (Chief Legal Officer · Dec 14, 2023 – Dec 14, 2023 · Past) | Director · Since at least Jan 1, 2024 |
| Michael Varney Other companies: Pardes Biosciences Inc (Director · Dec 23, 2021 – Aug 31, 2023 · Past); Foundation Medicine Inc (Director · Apr 7, 2015 – Apr 7, 2015 · Past) | Chair of R&D, SAB Member and Board Director · Since at least Jul 15, 2021 |
| Alexander W. Casdin Other companies: Sientra Inc (Director · Jun 15, 2023 – Jun 15, 2023 · Past) | Director · Since at least Jul 15, 2021 |
| Charles S. Fuchs Other companies: CytomX Therapeutics, Inc. (Director · Since at least Oct 23, 2017) | President, Research and Development · Since at least Aug 10, 2026 |
| Ebun Garner Other companies: Alphatec Holdings, Inc. (General Counsel and SVP · May 15, 2012 – Dec 12, 2016 · Past) | Chief Legal Officer · Since at least Jul 15, 2021 |
| Chandra Lovejoy | Chief Regulatory Affairs Officer · Since at least Nov 5, 2026 |
| David Chacko | Chief Financial Officer and Chief Business Officer · Since at least Nov 5, 2026 |
| Jonathan E. Lim | Chairman, CEO and Co-founder · Since at least Sep 10, 2026 |
| Julie Hambleton | Board Director · Since at least Nov 5, 2026 |
| Lisa Tesvich-Bonora | Chief People Officer · Since at least Nov 5, 2026 |
| Nik Chetwyn | Chief Operating Officer · Since at least Nov 4, 2026 |
| Robert Shoemaker | Chief Scientific Officer · Since at least Nov 12, 2025 |
| Shannon Morris | Chief Medical Officer · Since at least Feb 5, 2024 |
| Valerie Denise Harding Start | Director · Since at least Jun 24, 2025 |
| Val Harding | Board Director · Since at least Nov 5, 2026 |